O-7 - Around the World - Understanding Infectious Disease and Health Interventions

Co-Author(s)

• NB

  Nell Bond, PhD

  Post Doctoral Research Fellow
  Tulane University School of Medicine
  New Orleans, Louisiana

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• NB

  Natalie Bowman, MD, MPH

  Dr.
  University of North Carolina
  Chapel Hill, North Carolina

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• EB

  Eveline M. Bunge, PhD

  PhD
  Pallas Health Research and Consultancy, Rotterdam, the Netherlands
  Rotterdam, Zuid-Holland, Netherlands

  Disclosure: GSK group of companies (Research Grant or Support)
• JC

  Julie Clennon, PhD

  Adjunct Instructor
  Emory University College of Arts and Sciences
  Atlanta, Georgia

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• BC

  Beth Condori, BS

  Ms.
  Universidad Peruana Cayetano Heredia
  Lima, Lima, Peru

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• EE

  Emily Engel, MPH&TM

  Tulane VHFC Program Manager
  School of Medicine
  Tulane University
  New Orleans, Louisiana

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Jessica Fairley, MD MPH

  Associate Professor
  Emory University, Division of Infectious Diseases
  Atlanta, Georgia

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• JF

  José Ferreira, PhD

  Professor
  Faculdade da Saude e Ecologia Humana
  Vespasiano, Minas Gerais, Brazil

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• LF

  Lucia Fraga, PhD

  Professor
  Universidade Federal de Juiz de Fora - Campus GV
  Governador Valadares, Minas Gerais, Brazil

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• RG

  Robert Gilman, MD

  Dr.
  Johns Hopkins University
  Baltimore, Maryland

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• MG

  Maria Aparecida Grossi, MD, PhD

  Professor
  Faculdade da Saude e Ecologia Humana
  Vespasiano, Minas Gerais, Brazil

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• BH

  Bernard Hoet, MD, FFPM

  Vice President Medical Affairs
  GSK, Wavre, Belgium
  Wavre, Brabant Wallon, Belgium

  Disclosure: GSK group of companies (Shareholder)
• EM

  Edith Malaga, BS

  Ms.
  Universidad Peruana Cayetano Heredia
  Lima, Lima, Peru

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• AO

  Adaora Okoli, MD, MPH

  Internal medicine resident physician
  Tulane university department of internal medicine
  Tulane University school of medicine
  New Orleans, Louisiana

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• FS

  Fernanda Salgado, MD, MSc

  Global Medical Affairs Manager, Hepatitis Portfolio
  GSK, Wavre, Belgium
  Wavre, Brabant Wallon, Belgium

  Disclosure: GSK group of companies (Employee)
• RS

  Robert Samuels, M.B.Ch.B

  Dr
  Vanderbilt School of Medicine, Visiting Scholar
  Nashville, Tennessee

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• JS

  John Schieffelin, MD, MSPH

  Associate Professor of Pediatrics
  Tulane University
  New Orleans, Louisiana

  Disclosure: Wolters-Kluwer (Independent Contractor)
• JS

  Jeffrey Shaffer, PhD

  Assistant Professor
  Tulane University
  New Orleans, Louisiana

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• FT

  Freddy Tinajeros, PhD

  Dr.
  Asociación Benéfica PRISMA
  Santa Cruz de la Sierra, Santa Cruz, Bolivia

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• FU

  Federico Urquizu, MD

  Dr.
  Percy Boland Women's Hospital
  Santa Cruz de la Sierra, Santa Cruz, Bolivia

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• Pv

  Pierre van Damme, MD, PhD

  professor
  medicine and health sciences
  University of Antwerp, Campus Drie Eiken
  Wilrijk, Antwerpen, Belgium

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• Rv

  Rosa C. van Hoorn, MSc

  MSc
  Pallas Health Research and Consultancy, Rotterdam, the Netherlands
  Rotterdam, Zuid-Holland, Netherlands

  Disclosure: GSK group of companies (Research Grant or Support)
• MV

  Manuela Verástegui, PhD

  Dr.
  Universidad Peruana Cayetano Heredia
  Lima, Lima, Peru

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presenting Author(s)

• 

  Anar Andani, BSc

  Director, Global Medical Affairs, Hepatitis Vaccines
  GSK, Wavre, Belgium
  Wavre, Brabant Wallon, Belgium

  Disclosure: GSK group of companies (Employee, Shareholder)

  Slides Slides and Audio
• 

  Sarah Talia Himmelfarb, MD

  Resident in Internal Medicine and Pediatrics
  Tulane University
  New Orleans, LA

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

  Slides Slides and Audio
• 

  Melissa Klein, MPH

  Ms.
  University of North Carolina at Chapel Hill
  Chapel Hill, North Carolina

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

  Slides Slides and Audio
• 

  Taylor Landay, MPH

  Graduate Researcher
  Emory University
  Atlanta, Georgia

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

  Slides Slides and Audio

Presentations:

• Post-ebola Syndrome Presents with Multiple Overlapping Symptom Clusters: Evidence from an Ongoing Cohort Study in Eastern Sierra Leone
  Sarah Talia Himmelfarb, MD – Tulane University; Nell Bond, PhD – Tulane University School of Medicine; Adaora Okoli, MD, MPH – Tulane University school of medicine; John Schieffelin, MD, MSPH – Tulane University; Jeffrey Shaffer, PhD – Tulane University; Robert J. Samuels, M.B.Ch.B – Vanderbilt School of Medicine, Visiting Scholar; Emily J. Engel, MPH&TM – Tulane University
• Risk Factors for Vertical Transmission of t. Cruzi infection in an Endemic Setting
  Melissa D. Klein, MPH – University of North Carolina at Chapel Hill; Freddy Tinajeros, PhD – Asociación Benéfica PRISMA; Edith Malaga, BS – Universidad Peruana Cayetano Heredia; Manuela Verástegui, PhD – Universidad Peruana Cayetano Heredia; Beth J. Condori, BS – Universidad Peruana Cayetano Heredia; Federico Urquizu, MD – Percy Boland Women's Hospital; Robert Gilman, MD – Johns Hopkins University; Natalie M. Bowman, MD, MPH – University of North Carolina
• Concerning Trends of Pediatric Leprosy in Minas Gerais, Brazil and Associations with Number of Municipality Medical Facilities
  Taylor Landay, MPH – Emory University; Julie A. Clennon, PhD – Emory University College of Arts and Sciences; José A. Ferreira, PhD – Faculdade da Saude e Ecologia Humana; Lucia A. Fraga, PhD – Universidade Federal de Juiz de Fora - Campus GV; Maria Aparecida F. Grossi, MD, PhD – Faculdade da Saude e Ecologia Humana; Jessica K. Fairley, MD MPH – Emory University, Division of Infectious Diseases
• Impact of Universal Mass Vaccination Programs of Children Against Hepatitis a with 2-dose and 1-dose Schedules: A Systematic Literature Review
  Anar Andani, BSc – GSK, Wavre, Belgium; Pierre van Damme, MD, PhD – University of Antwerp, Campus Drie Eiken; Eveline M. Bunge, PhD – Pallas Health Research and Consultancy, Rotterdam, the Netherlands; Fernanda Salgado, MD, MSc – GSK, Wavre, Belgium; Rosa C. van Hoorn, MSc – Pallas Health Research and Consultancy, Rotterdam, the Netherlands; Bernard Hoet, MD, FFPM – GSK, Wavre, Belgium